AGT and metabolic dysfunction-associated steatotic liver disease: AngII aggravated lipid accumulation in the FFA-treated hepatocytes resulting in oxidative stress and inflammation, indicating a pivotal role of AngII and irbesartan in NAFLD pathogenesis.